IBDEI13L ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17640,1,3,0)
 ;;=3^Chlamydial Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,17640,1,4,0)
 ;;=4^A56.02
 ;;^UTILITY(U,$J,358.3,17640,2)
 ;;=^5000340
 ;;^UTILITY(U,$J,358.3,17641,0)
 ;;=N81.12^^88^895^22
 ;;^UTILITY(U,$J,358.3,17641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17641,1,3,0)
 ;;=3^Cystocele,Lateral
 ;;^UTILITY(U,$J,358.3,17641,1,4,0)
 ;;=4^N81.12
 ;;^UTILITY(U,$J,358.3,17641,2)
 ;;=^331535
 ;;^UTILITY(U,$J,358.3,17642,0)
 ;;=N81.11^^88^895^23
 ;;^UTILITY(U,$J,358.3,17642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17642,1,3,0)
 ;;=3^Cystocele,Midline
 ;;^UTILITY(U,$J,358.3,17642,1,4,0)
 ;;=4^N81.11
 ;;^UTILITY(U,$J,358.3,17642,2)
 ;;=^331534
 ;;^UTILITY(U,$J,358.3,17643,0)
 ;;=N81.10^^88^895^24
 ;;^UTILITY(U,$J,358.3,17643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17643,1,3,0)
 ;;=3^Cystocele,Unspec
 ;;^UTILITY(U,$J,358.3,17643,1,4,0)
 ;;=4^N81.10
 ;;^UTILITY(U,$J,358.3,17643,2)
 ;;=^5015838
 ;;^UTILITY(U,$J,358.3,17644,0)
 ;;=R87.614^^88^895^25
 ;;^UTILITY(U,$J,358.3,17644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17644,1,3,0)
 ;;=3^Cytologic Evidence of Malig on Smear of Cervix
 ;;^UTILITY(U,$J,358.3,17644,1,4,0)
 ;;=4^R87.614
 ;;^UTILITY(U,$J,358.3,17644,2)
 ;;=^5019672
 ;;^UTILITY(U,$J,358.3,17645,0)
 ;;=N87.9^^88^895^35
 ;;^UTILITY(U,$J,358.3,17645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17645,1,3,0)
 ;;=3^Dysplasia of Cervix Uteri,Unspec
 ;;^UTILITY(U,$J,358.3,17645,1,4,0)
 ;;=4^N87.9
 ;;^UTILITY(U,$J,358.3,17645,2)
 ;;=^5015877
 ;;^UTILITY(U,$J,358.3,17646,0)
 ;;=R30.0^^88^895^36
 ;;^UTILITY(U,$J,358.3,17646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17646,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,17646,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,17646,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,17647,0)
 ;;=N92.1^^88^895^39
 ;;^UTILITY(U,$J,358.3,17647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17647,1,3,0)
 ;;=3^Excessive/Frequent Menstruation w/ Irregular Cycle
 ;;^UTILITY(U,$J,358.3,17647,1,4,0)
 ;;=4^N92.1
 ;;^UTILITY(U,$J,358.3,17647,2)
 ;;=^5015909
 ;;^UTILITY(U,$J,358.3,17648,0)
 ;;=Z08.^^88^895^41
 ;;^UTILITY(U,$J,358.3,17648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17648,1,3,0)
 ;;=3^F/U Exam After Malig Neop Treatment
 ;;^UTILITY(U,$J,358.3,17648,1,4,0)
 ;;=4^Z08.
 ;;^UTILITY(U,$J,358.3,17648,2)
 ;;=^5062667
 ;;^UTILITY(U,$J,358.3,17649,0)
 ;;=Z80.3^^88^895^42
 ;;^UTILITY(U,$J,358.3,17649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17649,1,3,0)
 ;;=3^Family Hx of Breast CA
 ;;^UTILITY(U,$J,358.3,17649,1,4,0)
 ;;=4^Z80.3
 ;;^UTILITY(U,$J,358.3,17649,2)
 ;;=^5063347
 ;;^UTILITY(U,$J,358.3,17650,0)
 ;;=Z80.49^^88^895^43
 ;;^UTILITY(U,$J,358.3,17650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17650,1,3,0)
 ;;=3^Family Hx of Genital Organ CA
 ;;^UTILITY(U,$J,358.3,17650,1,4,0)
 ;;=4^Z80.49
 ;;^UTILITY(U,$J,358.3,17650,2)
 ;;=^5063351
 ;;^UTILITY(U,$J,358.3,17651,0)
 ;;=Z80.41^^88^895^44
 ;;^UTILITY(U,$J,358.3,17651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17651,1,3,0)
 ;;=3^Family Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,17651,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,17651,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,17652,0)
 ;;=N73.9^^88^895^47
 ;;^UTILITY(U,$J,358.3,17652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17652,1,3,0)
 ;;=3^Female Pelvic Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,17652,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,17652,2)
 ;;=^5015820
